1. Hirokazu Kanegane. Ten-year prospective for the region (APSID role). IPOPI 5th Regional Asian PID Meeting 2024.03.25 東京

  1. Hirokazu Kanegane. Flow cytometry use in Primary Immunodeficiency disorders. Mini-symposium: Inborn errors of immunity 2023.10.27 Bangkok

  2. Hirokazu Kanegane. NK cell assays. APSID 2023 2023.10.26 Singapore

  3. Hirokazu Kanegane. Diagnosis and Management of Primary Atopic Disorder. APAAACI 2023 2023.10.25 Singapore

  4. Hirokazu Kanegane. Rare diseases presenting with hemophagocytic lymphohistiocytosis. IEI SCAC 2023 2023.09.15 重慶

  5. Satoshi Miyamoto, Daiki Niizato, Takahiro Kamiya, Takeshi Isoda, Masatoshi Takagi, Shohei Azumi, Shinsuke Hirabayashi, Kenichi Sakamoto, Kenji Kishimoto, Takako Miyamura, Katsutsugu Umeda, Masakatsu Yanagimachi, Kaori Kanda, Yasuhiro Ikawa, Kenichiro Watanabe, Tatsuo Ichinohe, Hirotoshi Sakaguchi, Tomohiro Morio, Hirokazu Kanegane. Allogenic hematopoietic cell transplantation with alemtuzumab in Asian patients with inborn errors of immunity. ICBMT2023 2023.09.01 Busan

  6. Dan Tomomasa, Tasuku Suzuki, Ichiro Takeuchi, Kimitoshi Goto, Shin-Ichiro Hagiwara, Dai Keino, Satoshi Saida, Takashi Ishige, Takahiro Kudo, Masataka Ishimura, Motohiro Kato, Yoji Sasahara, Tomohiro Morio, Katsuhiro Arai, Hirokazu Kanegane. Clinical and genetic characteristics of IL10RA deficiency patients in Japan. The 2nd International Symposium of Clinical Immunology 2023.05.19 神奈川

  7. Hirokazu Kanegane. HLH associated with inborn errors of metablism and familial hemophagocytic lymphohistiocytosis in adult. 2nd National Congress of Inborn Errors of Immunity and National Forum on Pediatric Immunology (IEI China 2023 and FOPI) 2023.04.26 Web開催

  8. Mahnaz Jamee, Hirokazu Kanegane. Lung Surgery in STAT3 loss-of-function mutation: is it advisable?. APSID 2023 2023.04.22 香港

  1. Hirokazu Kanegane. Advanced therapies: The future of BMT in Asia. IPOPI 4th Regional Asian PID Meeting 2022.11.19 Kuala Lumpur

  2. Hirokazu Kanegane. Finding NEMO. The 1st National IEI Congress of China 2022 2022.11.12 Web開催

  3. Hirokazu Kanegane. Hematopoietic stem cell transplantation for PID. 17th Congress of Asian Society for Pediatric Research (ASPR 2022) 2022.09.17 Web開催

  4. Hirokazu Kanegane. A B-Cell Deficient Japanese Girl with ZIP7 Deficiency Caused by Novel Compound Heterozygous Variants in SLC39A7. 13th International Congress of Immunodeficiency Diseases 2022.04.24 Web開催

  5. Hirokazu Kanegane. ALPS & ALPS-like and IPEX & IPEX-like. . 4th Asia-Pacific Society for Immunodeficiencies Congress 2022.04.02 Web開催

  6. Hirokazu Kanegane. An Approach to Antibody Deficencies.. 4th Asia-Pacific Society for Immunodeficiencies Congress 2022.04.01 Web開催

  1. Hirokazu Kanegane. Updates in Primary antibody deficiencies. 16th Congress of Asian Society for Pediatric Research (ASPR 2021) 2021.12.11 Web開催

  2. Hirokazu Kanegane. Tips of hematopoietic cell transplantation for inborn errors of immunity. Chinese PID Summer School 2021 2021.09.25 Web開催

  3. Hirokazu Kanegane. Revisiting X-linked agammaglobulinemia. 12th International Congress of Immunodeficiency Diseases(ICID) 2021.04.27 Web開催

  1. Akihiro Hoshino, Yuya Koda, Jun Kato, Kay Tanita, Hirokazu Kanegane . A plastic anemia as an initial manifestation in a patient with SAP deficiency. The 27th Annual Meeting of the Japan Childhood Aplastic Anemia Study Group 2020.11.08 Web開催

  2. K. Tanita, F. Sakura, M. Tsumura, H. Ohnishi, A. Hoshino, K. Suzuki, S. Okada, R. Nambu, S. Umetsu, K. Imai, T. Morio, H. Kanegane. PATIENTS WITH THE GAIN-OF-FUNCTION MUTATIONS IN STAT3 PRESENT WITH A VARIETY OF AUTOIMMUNE DISEASES. 19th Biennial Meeting of The European Society of immunodeficiencies (ESID 2020) 2020.10.14 web

  3. Yoonsun Yoon, Ji-man Kang, Junsik Choi, Kangmo Ahn, Keon Hee Yoo, Eun-Suk Kang, Kyoung-Mee Kim, Jung Eun Lee, Geum-Youn gawk, Kihyun Kim, Kosuke Imai, Hirokazu Kanegane, Yae-jean Kim. Cancer development in a Korean family with CTLA-4 haploinsufficiency. The 3rd Annual Scientific Meeting of the Japanese Society for Immunodeficiency and Autoinflammatory Diseases (JSIAD) 2020.02.16 東京

  4. Miko Okamura, Kay Tanita, Hidetoshi Takada, Tetsuo Mitsui, Yoshiyuki Minegishi, Kohsuke Imai, Tomohiro Morio, Hirokazu Kanegane. Somatically reverted T cells in dedicator of cytokinesis 8 deficiency modify cellular immunity. 3rd Scientific Congress of Asia Pacific Society for Immunodeficiencies 2020.02.09 Chandigarh, India

  5. Takahiro Tomoda, Tsubasa Okano, Kento Inoue, Motoi Yamashita, Takahiro Kamiya, Takeshi Isoda Masakatsu Yanagimachi, Hirokazu Kanegane, Masatoshi Takagi, Tomohiro Morio, Kohsuke Imai. Second transplantation rescued the graft failure after hematopoietic stem cell transplantation. 3rd Scientific Congress of Asia Pacific Society for Immunodeficiencies 2020.02.09 Chandigarh, India.

  6. Takahiro Tomoda, Tsubasa Okano, Kento Inoue, Motoi Yamashita, Takahiro Kamiya, Takeshi Isoda, Masakatsu Yanagimachi, Hirokazu Kanegane, Masatoshi Takagi, Tomohiro Morio, Kohsuke Imai. An intractable case of hyper IgE syndrome. APSID (Asia Pacific Society for Immunodeficiencies) School cum Workshop 2020.02.06 Chandigarh, India.

  1. Okano T, Imai K, Naruto T, Okada S, Okamoto K, Yamashita M, Yeh T. W, Takagi M, Kanegane H, Morio T　. Diagnostic Approach by Whole Exome Sequencing for 141 Patients of Inborn Errors of Immunity　. 2019 Focused Meeting of the European Society of Immunodeficiencies (ESID2019) 2019.10.18 Brussels, Belgium

  2. Hoshino A, Okano T, Matsumoto K, Nishimura A, Shintaku H, Tokoro S, Okamoto H, Wada T, Mitsuiki N, Kajiwara M, Takagi M, Imai K, Kanegane H, Morio T. Plasmacytoma-Like Post-Transplant Lymphoproliferative Disorder with Multiple Autoantibodies in a XIAP Deficient Patient　. 2019 Focused Meeting of the European Society of Immunodeficiencies (ESID2019) 2019.10.18 Brussels, Belgium

  3. Nishimura A, Naruto T, Hoshino A, Amano K, Iwamoto S, Hirayama M, Grigg A, Bosco J J, Migita M, Takagi M, Ohara O, Morio T, van Zelm MC, Kanegane H. Genomics Analysis of Leukemia Predisposition in X-Linked Agammaglobulinemia. 2019 Focused Meeting of the European Society of Immunodeficiencies (ESID2019) 2019.09.20 Brussels

  4. Hoshino A, Okano T, Matsumoto K, Nishimura A, Shintaku H, Tokoro S, Okamoto H, Wada T, Mitsuiki N, Kajiwara M, Takagi M, Imai K, Kanegane H, Morio T. Plasmacytoma-Like Post-Transplant Lymphoproliferative Disorder with Multiple Autoantibodies in a XIAP Deficient Patient. 2019 Focused Meeting of the European Society of Immunodeficiencies (ESID2019) 2019.09.20 Brussels

  5. Honda Y, Yasumi T, Miyamoto T, Nishitani M, Nihira H, Shiba T, Shibata H, Tanaka T, Kanda K, Izawa K, Kanegane H, Heike T, Takita J, Nishikomori R.. A CTLA-4 Haploinsufficiency Case with Multiple Brain and Pulmonary Lesions - Dilemmas in Management. 19th Biennial Meeting of the European Society of Immunodeficiencies (ESID2019). 2019.09.20 Brussels

  6. Cardinez C, Miraghazadeh B, Tanita K, da Silva E, Hoshino A, Okada S, Chand R, Asano T, Tsumura M, Yoshida K, Ohnishi H, Kato Z, Yamazaki M, Okuno Y, Miyano S, Kojima S, Ogawa S, Andrews TD, Field MA, Burgio G, Morio T, Vinuesa CG, Kanegane H, Cook M. Gain-of-Function IKBKB Mutation Causes Human Combined Immune Deficiency. 2019 Focused Meeting of the European Society of Immunodeficiencies (ESID2019) 2019.09.19 Brussels

  7. Okano T, Imai K, Naruto T, Okada S, Okamoto K, Yamashita M, Yeh T. W, Takagi M, Kanegane H, Morio T. Diagnostic Approach by Whole Exome Sequencing for 141 Patients of Inborn Errors of Immunity. 2019 Focused Meeting of the European Society of Immunodeficiencies (ESID2019) 2019.09.19 Brussels

  8. Kanegane H. Revisit X-linked agammaglobulinemia. 2019 Samsung Medical Center Primary Immunodeficiency Symposium. 2019.07.06 Seoul

  9. Nishimura Akira, Aoki Yuki, Ishiwata Yasuyoshi, Inoue Maiko, Ichimura Takuya, Ueyama Junichi, Matsumoto Kazuaki, Inoue Kento, Hiroki Haruka, Ono Shintaro, Okano Tsubasa, Tanaka Mari, Miyamoto Satoshi, Ashiarai Miho, Miyawaki Reiji, Yamagishi Chika, Tezuka Mari, Okawa Teppei, Hoshino Akihiro, Endo Akifumi, Yasuhara Masato, Kamiya Takahiro, Mitsuiki Noriko, Ono Toshiaki, Yanagimachi Masakatsu, Isoda Takeshi, Tomizawa Daisuke, Nagasawa Masayuki, Kajiwara Michiko, Takagi Masatoshi, Mizutani Shuki, Kanegane Hirokazu, Imai Kohsuke, Morio Tomohiro. Hematopoietic cell transplantation with reduced intensity conditioning regimen using fludarabine/busulfan and fludarabine/melphalan for primary immunodeficiency diseases . The 45th Annual Meeting of the European Society for Blood and Marrow Transplantation 2019.03.25 Frankfurt

  10. Yeh TW, Okano T, Okamoto K, Yamashita M, Takashima T, Mitsuiki N, Okada S, Kanegane H, Imai . APRIL deficiency as a cause of common variable immunodeficiency. 第2回日本免疫不全・自己炎症学会総会・学術集会 2019.02.02 東京

  11. Tanita K, Cardinez C, Miraghanzadeh B, Hoshino A, Okada S, Asano T, Tsumura M, Ohnishi H, Kato Z, Morio T, Vinuesa CG, Kanegane H, Cook MC. Gain-of-function IKBKB mutation causes human combined immune deficiency. 第2回日本免疫不全・自己炎症学会総会・学術集会 2019.02.02 東京

  12. Yamada Y, Cho K, Agematsu K, Kanegane H, Miyake N, Ueki M, Akimoto T, Kobayashi N, Ikemoto S, Tanino M, Fujita A, Hayasaka I, Miyamoto S, Tanaka-Kubota M, Nakata K, Shiina M, Ogata K, Minakami H, Matsumoto N, Ariga T. Heterozygous mutations in OAS1 cause infantile-onset pulmonary alveolar proteinosis with hypogammaglobulinemia. 第2回日本免疫不全・自己炎症学会総会・学術集会 2019.02.02 東京

  1. Kanegane H.. Modification of cellular and humoral immunity by somatically reverted T cells in XLP1. XLP Symposium 2018. 2018.10.29 London

  2. Yeh T. W, Okano T, Okamoto K, Yamashita M, Takashima T, Mitsuki N, Okada S, Kanegane H, Imai K, Morio T.. April Deficiency as a Cause of Common Variable Immunodeficiency. . 18th Biennial Meeting of the European Society of Immunodeficiencies (ESID2018) 2018.10.25 Lisbon

  3. Kanegane H. Epstein-Barr related Primary Immunodeficiency. CME Lecture 2018.05.21 Singapore

  4. Kanegane H. Chronic Active Epstein-Barr Virus & Epstein-Barr Virus associated with Haemophagocytic Lymphohistiocytosis. CME Lecture 2018.05.21 Singapore

  5. Kanegane H. Management of HLH and XLP. APSID 2018 Summer School 2018.05.07 Chonquing, China

  6. Yeh TW, Okano T, Okamoto K, Yamashta M, Takashima T, Mitusiki N, Okada S, Kaneganwe H, Imai K, Morio T. APRIL deficiency a as a cause of common variable immunodeficiency. The 2nd APSID Scientific Congress 2018.05.07 Chonquing, China

  7. Kanegane H. EBV associated PID. The 2nd APSID Scientific Congress 2018.05.07 Chonquing, China

  8. Okamoto K, Shigemizu D, Okano T, Yeh TW, Takashima T, Yamashita M, Ono S, Mitsuiki N, Takagi M, Mori M, Kanegane H, Tsunoda T, Imai K, Morio T. Whole exome sequence analysis using the known and candidate genes for primary immunodeficiency diseases. The 2nd APSID Scientific Congress 2018.05.07 Chonquing, China

  1. Cho K, Yamada M, Agematsu K, Kanegane H, Miyake N, Ueki M, Akimoto T, Kobayashi N, Ikemoto S, Tanino M, Fujita A, Hayasaka I, Miyamoto S, Nakata K, Shiina M, Ogata K, Minakami H, Matsumoto N, Ariga T. A New Type of Primary Immunodeficiency with Pulmonary Alveolar Proteinosis due to OAS1 Dysfunction. ESID 2017 2017.09.13 Edinburgh, UK

  2. Kodawaki T, Ohnishi H, Kanegane H, Kawamoto N, Hori T, Nishimura K, Kobayashi C, Shigemura T, Ogata S, Inoue Y, Kawai T, Hiejima E, Takagi M, Imai K, Nishikomori R, Ito S, Heiki T, Ohara O, Morio T, Fukao T. A Nation-wide Survey of Haploinsufficiency of A20 Reveals the Frequent Coincidence of Autoimmunity in Japan. ESID 2017 2017.09.13 Edinburgh, UK

  3. Ono S, Yanagimachi M, Okano T, Hoshino A, Takagi M, Imai K, Morio T, Kanegane H. Inflammatory Bowel Disease Associated with XIAP Deficiency can be cured by Hematopoietic Stem Cell Transplantation. ESID 2017 2017.09.12 Edinburgh, UK

  4. Okano T, Imai K, Mitui-Sekinaka K, Yeh T.W, Takashima T, Kanegane H, Nonoyama S, Morio T. Combined Immunodeficiency and Progressive Lymphoproliferative Diseases of Activated P13Kγ Syndrome Rescued by Hematopoietic. ESID 2017 2017.09.12 Edinburgh, UK

  5. Okamoto K, Okano T, Kumaki E, Tanaka E, Ono S, Wada T, Ohnishi H, Kato Z, Nunoi N, Imai K, Kanegane H, Mori M, Morio T. A Case of Non-Pulmonary Sarcoidosis Due to Novel Hypomorphic Missense Mutation of NCF2. ESID 2017 2017.09.11 Edinburgh,UK

  1. Kanegane H. Recent advances in primary antibody immunodeficiency and immunoglobulin replacement therapy. 21th Congress of Chinese Pediatric Society 2016.10 Zhuhai, PRC

  2. Ono S, Okano T, Hoshino A, Yanagimachi M, Takagi M, Imai K, Morio T, Kanegane H. Hematopoietic　stem　cell　transplantation for XIAP deficiency. XLP-WAS 2016 Symposium-London 2016.09.26 London, UK

  3. Kanegane H, Hoshino A, Takashima T, Yeh T-W, Okano T, Yamashita M, Imai K, Morio T. . Selective dysregulation of Epstein Barr virus infection in hypomorphic ZAP70 mutation. XLP-WAS 2016 Symposium-London 2016.09.26 London, UK

  4. Jolles S, Rojavin M, Nelson Jr. R, Wasserman R.L, Borte M, Kanegane H, Imai K.. Efficacy and Safety of HIZENTRA in Patients with Primary Immunodeficiency in Japan, Europe, and the US. 17th Biennial Meeting of17th Biennial Meeting of the European Society for Immunodeficiencies 2016.09.23 Barcelona, Spain

  5. Okano T, Watanabe E, Takashima T, Nishikawa T, Kawano Y, Tomoda T, Tanaka-Kubota M, Miyamoto S, Yeh T, Yamashita M, Tanaka K, Mitusiki N, Ohara O, Takagi M, Imai K, Kanegane H, Morio T.. IGG1 Gammopathy in X-SCID Caused by Maternal T and B cell Engraftment. 17th Biennial Meeting of the European Society for Immunodeficiencies 2016.09.23 Barcelona, Spain

  6. Moriya K, Tanita K, Ohnishi H, Niizuma H, Rikiishi T, Nishikomori R, Ishige T, Imai K, Kanegane H, Sasahara Y, Arakawa H, Kure S, Morio T. I B-α S32 Mutations Underly Ectodermal Dysplasia with Immunodeficiency Manifestations and Correlation with Immunological Parameters.. 17th Biennial Meeting of the European Society for Immunodeficiencies 2016.09.23 Brcelona, Spain

  7. Rojavin M, Kanegane H, Borte H, Imai K, Hubsch A, Jolles S.. Analysis of Patient Treatment Satisfaction from Five Studies of HIZENTRA 20% Subcutaneous Immunoglobulin. 17th Biennial Meeting of the European Society for Immunodeficiencies 2016.09.23 Barcelona, Spain

  8. Schwab C, Gabrysch A, Hoshino M, Slatter M, Hayakawa S, Schubert D, Klemann C, Frede N, Salzer U, Speckmann C, Freiberger T, Lorenz H.M, Hauck F, Klobuch S, Zeissig S, Leichtner A, Van de Veerdonk F, Elemnto O, Giulino-Roth L, Duckers G, Niehues T, Alsina L, Deya-Martinez A, Kanderiva V, Fronkova E, Price C, Patino V, Blumberg R, Yesim Kucuk Z, Seneviratne S, Kanariou M, Lougaris V, Albert M, Giese T, Litzman J, Ehl S, Okada S, Imai K, Dybedai I, Tasken K, Wolff D, Warnatz K, Hambleton S, Arkwright P, Cant A, Kanegane H, Grimbacher B.. The Clinical Spectrum and Treatment Options of 82 Individuals with CTLA-4Deficiency. 17th Biennial Meeting of the European Society for Immunodeficiency 2016.09.22 Barcelona, Spain

  9. Mitsui-Sekinaka K, Imai K, Tsujita Y, Mitsuiki N, Asano T, Sekinaka Y, Kanegane H, Yoshida K, Miyano S, Kojima S, Ogawa S, Ohara O, Okada S, Kobayashi M, Takagi M, Morio T, Nonoyama S.. Activated PI3 Kinase Delta Syndrome (APDS)-Like Immunodeficiency Caused by PTEN Mutation. 17th Biennial Meeting of the European Society for Immunodeficiencies 2016.09.22 Barcelona, Spain

  10. Hoshino A, Okada S, Yoshida K, Nishida N, Yamashita M, Okano T, Tsumura M, Nishimura S, Sakata S, Takagi M, Imai K, Miyano S, Ogawa S, Kojima S, Nonoyama S, Morio T, Kanegane H. . Abnormal Hematopoiesis and Autoimmunity in Humans with Germline IKZF1 Mutations. 17th Biennial Meeting of the European Society for Immunodeficiencies 2016.09.22 Barcelona, Spain

  11. Okano T, Imai K, Tsujita Y, Mitsuiki , Mitsui-Sekinaka K, Takashima T, Kanegane H, Nonoyma S. Broad Spectrum of Clinical Manifestations and Outcome of Hematopoietic Stem Cell Transplantation in Japanese Patients with Activated P13KD Syndrome Type1. ASPID Spring School 2016.05.01 Hong Kong

  12. Kanegane H. Immunoglobulin Replacement for Agammaglobulinemia – Intravenous or Subcutaneous?. ASPID Spring School 2016.05.01 HongKong

  13. Kanegane H. Use of Flow Cytometry in PID diagnosis.. APSID Spring School 2016.04.28 Hong Kong

  14. Mikhail Rojavin, Hirokazu Kanegane, Michael Borte, Imai k , Alphonse P. Hubsch, Helena Soop, Stephen R. Jolles. Pooled Analysis of Patient Treatment Satisfaction from Five Hizentra Studies. 2016 AAAAI ANNUAL MEETING 2016.03.04 Los Angeles

  1. Hirokazu Kanegane. XLP (X-linked lympho proliferative syndrome) and Epstein-Barr virus infection.. V Simpósio Internacional de Immunodeficiências Primárias—SIDEP, 5 2015.05.20

  2. Ogashiwa T, Kunisaki R, Yasuhara H, Tsuda S, Koh R, Yazawa K, Gotoh K, Kimura H, Sugita A, Mori M, Tanaka M, Kanegane H, Maeda S. Clinical, Morphological and Histological Features of X-linked Lymphoproliferative Syndrome Type 2 Enteritis Diagnosed in three Cases with Childhood Onset Inflammatory Bowel Disease. 10th Congress of ECCO - Inflammatory Bowel Diseases. 10th Congress of ECCO - Inflammatory Bowel Diseases 2015.02.18 Barcelona

  1. Kanegane H. Whole exome sequencing reveals atypical phenotype of X-linked lymphoproliferative syndrome.. A symposium for researchers and clinicians on XLP WAS 2014.11.03 London, UK

  2. Yang X, Nishida N, Hoshino A, Goi K, Kanzaki T, Yoshida K, Muramatsu H, Ogawa S, Kojima S, Kanegane H. X-linked dysgammaglobulinemia associated with somatically reverted memory T cells in a family with X-linked lymphoproliferative syndrome type 1. 16th Biennial Meeting of the European Society of Immunodeficiencies 2014.10 Prague, Czech Rep

  3. Aguilar C, Lenoir C, Lambert N, Begue B, Brousse N, Canioni D, Berrebi D, Roy M, Gerart S, Chapel H, Schwerd T, Siproudhis L, Schappi M, Al-Ahmari A, Yamaide A, Mori M, Galicier L, Neven B, Routes J, Ulhig H, Koletzko S, Patel S, Kanegane H, Picard C, Fischer A, Cerf Bensussan N, Ruemmele F, Hugot J.P, Latour S. Characterization of crohn disease in X-linked inhibitor of apoptosis protein-deficient male patients and female symptomatic carriers. 16th Biennial Meeting of the European Society of Immunodeficiencies 2014.10 Prague, Czech Rep

  4. Mitsuiki N, Yang X, Bartol S, Kosaka Y, Takada H, Imai K, Kanegane H, Mizutani S, Van der Burg M, Van Zelm M, Ohara O, Morio T. Mutations in Bruton’s tyrosine kinase impair IgA responses. 16th Biennial Meeting of the European Society of Immunodeficiencies 2014.10 Prague, Czech Rep

  5. Hoshino A, Okuno Y, Migita M, Ban H, Yang X, Kiyokawa N, Kojima S, Ohara O, Kanegane H. B-precursor acute lymphoblastic leukemia in a patient with X-linked agammaglobulinemia. 16TH Biennial Meeting of the European Society of Immunodeficiencies 2014.10

  6. Nishida N, Yang X, Hoshino A, Kanegane H. Inflammatory bowel disease in Japanese patients with xiap deficiency. 16th Biennial Meeting of the European Society of Immunodeficiencies 2014.10 Prague, Czech Rep

  7. Kanegane H, Imai K, Yamada M, Takada H, Ariga T, Hara T, Rojavin M, Hu W, Hubsch A, Nonoyama S. Safety and tolerability of hizentra in patients with primary immunodeficiency in Japan, Europe and the US. 16th Biennial Meeting of the European Society of Immunodeficiencies 2014.10 Prague, Czech Rep

  8. Takashima T, Tsujita Y, Yeh T.W, Mitsuiki N, Kanegane H, Kracker S, Durandy A, Nonoyama S, Morio T, Imai K. Clinical and immunological features of patients with Gain-of-Function PIK3CD mutations in Japan. 16th Biennial Meeting of the European Society of Immunodeficiencies 2014.10 Prague, Czech Rep

  1. Allogenic HCT with alemtuzumab in pediatric patients with inborn errors of immunity. 2023.02.12

  2. Two cases of late-onset familial hemophagocytic lymphohistiocytosis type 3 presenting with CLIPPERS-like syndrome. 2023.02.12

  3. Wiskott-Aldrich syndrome due to chromosomal structural abnormalities. 2023.02.12

  4. Support for adolescent patients and their families by HSC coordinators in fertility preservation. 2023.02.11

  5. A case of relapsed AML maintained complete remission by re-transplantation using clofarabine. 2023.02.11

  6. Hematopoietic cell transplantation for patients with inborn errors of immunity. 2023.02.11

  7. Efficacy of JAK inhibitors for patients with gain-of-function mutation of STAT3. 2023.02.11

  8. Comparison of adult and pediatric cases with hyper-IgE syndrome caused by function in STAT3. 2023.02.11

  1. EBV reactivation and nephrotic syndrome associated with chronic GVHD after allogeneic hematopoietic cell transplantation for GATA2 deficiency. 2022.11.26

  2. Sinusoidal obstruction syndrome during induction remission therapy for FUS-ERG-positive BCP-ALL. 2022.11.26

  3. A case of unrelated bone marrow transplantation with alemtuzumab-based conditioning regimen for XIAP deficiency. 2022.11.26

  4. BCP-ALL Inotuzumab ozogamicin successfully controlled the TCF3-HLF-positive acute lymphoblastic leukemia before hematopoietic cell transplantation. 2022.11.25

  5. A PAX5 germline variant in a patient with common variable immunodeficiency complicated with B-cell acute lymphoblastic leukemia. 2022.11.25

  6. Polatuzumab vedotin, bendamustine and rituximab (Pola-BR) for diffuse large B cell lymphoma in a patient with Bloom syndrome. 2022.11.25

  7. Cytokine monitoring for disease status evaluation in a patient with chronic active Epstein-Barr virus infection. 2022.11.25

  8. Umbilical cord blood transplantation for a patient with CHARGE syndrome and severe combined immunodeficiency. 2022.11.25

  9. Stem cell transplantation for XLP1 with EBV-associated hemophagocytic lymphohistiocytosis. 2022.05.14

  10. Role of Hematopoietic Cell Transplant Coordinator in transition from childhood to adulthood. 2022.05.14

  11. Alemtuzumab-containing reduced intensity conditioning for two cases with PI3K-delta syndrome. 2022.05.13

  12. Allogeneic hematopoietic cell transplantation for asymptomatic patients with SAP deficiency. 2022.05.13

  13. International retrospective study of allogeneic HCT for X-linked agammaglobulinemia. 2022.05.13

  14. A case of bone marrow transplantation to activated P13KDelta syndrome type 1 (APDS1). 2022.02.12

  1. Epstein-Barr Virus-negative granulomatous disease due to SAP deficiency; a case report. 2021.11.25

  2. Successful TCRABCD 19-depleted hematopoietic cell transplantation for a patient with Artemis deficiency. 2021.11.25

  3. A study of adenosine deaminase 2 deficiency by multi-omics analysis. 2021.02.07

  4. Delayed recovery of chimeric status after non-myeloablative cord blood transplantation in a patient with DNA ligase IV deficiency. 2021.02.06

  1. A retrospective study of six cases of HLA haplo-identical hematopoietic stem cell transplantation with Post-Transplant Cyclophosphamide. 2020.11.22

  2. Ruxolitinib administration for two cases with steroid-refractory lung GVHD. 2020.11.22

  3. Inflammatory bowel disease associated with XIAP deficiency can be cured by allogeneic hematopoietic cell transplantation. 2020.11.22

  4. Salvage haploidentical bone marrow transplant using post-transplant cyclophosphamide for graft failure in a patient with EDA-ID due to NEMO deficiency. 2020.11.22

  5. Allogeneic hematopoietic stem cell transplantation from haploidentical donors for non-malignant diseases with post-transplantation cyclophosphamide and anti-thymoglobulin. 2020.11.22

  6. A case of relapsed infant ALL with MLL rearrangement who underwent CAR-T cell therapy. 2020.11.21

  7. CAR-T Therapy Practice: Through experience under various situations. 2020.11.21

  8. Genomics analysis of leukemia predisposition in X-linked agammaglobulinemia. 2020.02.16

  9. 175 cases of genetic testing by health insurance for primary immunodeficiency in Japan. 2020.02.16

  1. Succesful case of donor lymphocyte infusion for refractory T cell acute lymphoblastic leukemia which lead to one year of remission. 2019.11.16

  2. Intrinsically Vancomycin resistant enterococcal (Enterococcus gallinarum) meningitis occurred early after hematopoietic stem cell transplantation for activated PI3K delta syndrome type2. 2019.11.16

  3. Pay attention to selective Immunoglobulin G2 deficiency - a case of Invasive pneumococcal infection after allogenic hematopietic stem cell transplantation. 2019.11.16

  4. Usefulness of respiratory infection early diagnosis with multiplex PCR method for immunocompromised patients. 2019.11.16

  5. A case with relapsed acute lymphoblastic leukemia treated with blinatumomab under the active GVHD after unrelated bone marrow transplantation. 2019.11.15

  6. Efficacy of Azacitidine for MDS due to germline GATA2 haploinsufficiency. 2019.11.14

  7. BRAFV600E-POSITIVE PRECURSORS AS MOLECULAR MARKERS OF BONE MARROW INVOLVEMENT IN PEDIATRIC LANGERHANS CELL HISTIOCYTOSIS. 2019.11.14

  8. Clonal evolution of leukemia with MLL-AF9 from myeloid to T-lineage. 2019.11.14

  9. A case of type 1 hyper-IgE syndrome with leukemoid reaction in an infant. 2019.11.14

  10. Treatment of platelet transfusion refractoriness in patients with Wiskott-Aldrich syndrome. 2019.11.14

  11. Genetic test for the suspected patients of inborn errors of immunity. 2019.11.07

  12. An adult case of cytotoxic T-lymphocyte antigen 4 (CTLA-4) insufficiency treated successfully with abatacept. 2019.02.03

  13. An experience of allogenic stem cell transplantation for NFKB1 deficiency. 2019.02.03

  14. Three families with X-linked agammaglobulinemia caused by transcriptional. 2019.02.03

  15. Combined immunodeficiency of ICF syndrome. 2019.02.03

  16. Hematopoietic cell transplantation with reduced intensity conditioning regimen using fludarabine/busulfan and fludarabine/melphalan for primary immunodeficiency diseases . 2019.02.02

  1. A 7-year-old girl who maintain complete remission after multiple hematopoietic cell transplantation for frequent relapse of infant leukemia. 2017.11.11

  2. A case of CTLA4 hapioinsufficiency found by lymphadenopathy. 2017.11.11

  3. A case of T-cell hymphoblastic lymphoma/leukemia complicated by gait inability during combination chemotherapy with nelarabine. 2017.11.10

  4. Kudo K, Maeda M, Suzuki N, Kanegane H, Ohga S, Ishii E, Shioda Y, Imamura T, Imashuku S, Tsunematu Y, Endo M, Shimada A, Koga Y, Hashii Y, Inagaki J, Inoue M, Tabuchi K, Morimoto A. Hematopoietic stem cell transplamtation in children with refractory Langerhans cell histiocytosis. 2017.11.09

  5. Central venous catheter-related cylindrical thrombosis in right atrium after bone marrow transplantation for X-linked anhidrotic ectodermal dysplasia with immunodeficiency(XL-EDA-ID). 2017.11.09

  1. Akihiro Hoshino, Satoshi Okada, Kenichi Yoshida, Yusuke Okuno, Miyuki Tsumura, Shiho Nishimura, Sonoko Sakata, Masatoshi Takagi, Kohsuke Imai, Yuichi Shiraishi, Kenichi Chiba, Hiroko Tanaka, Satoru Miyano, Seishi Ogawa, Seiji Kojima, Shigeaki Nonoyama, Tomohiro Morio, Hirokazu Kanegane. ABNORMAL HEMATOPOIESIS AND AUTOIMMUNITY IN HUMANS WITH GERMLINE IKZF1 MUTATIONS. 2016.12.16

  2. Akihiro Hoshino, Satoshi Okada, Kenichi Yoshida, Naonori Nishida, Yusuke Okuno, Hiroo Ueno, Motoi Yamashita, Tsubasa Okano, Miyuki Tsumura, Shiho Nishimura, Sonoko Sakata, Masatoshi Takagi, Kohsuke Imai, Yuichi Shiraishi, Kenichi Chiba, Hiroko Tanaka, Satoru Miyano, Seishi Ogawa, Seiji Kojima, Shigeaki Nonoyama, Tomohiro Morio, Hirokazu Kanegane. ABNORMAL HEMATOPOIESIS AND AUTOIMMUNITY IN HUMANS WITH GERMLINE IKZF1 MUTATIONS. 2016.10.21

  3. Akihiro Hoshino, Hirokazu Kanegane. ABNORMAL HEMATOPOIESIS AND AUTOIMMUNITY IN HUMANS WITH GERMLINE IKZF1 MUTATIONS. 2016.05.27

  1. Pediatric Hodgkin's lymphoma subsequently diagnosed as common variable immunodeficiency with FAS mutation. 2020.11.22

To the head of this page.▲